Bionano Genomics, Inc. is making waves in the world of genomics with its innovative genome analysis software. Designed for genomics labs, Bionano's software allows users to analyze and interpret data across a range of platforms to produce informative data visualizations, making reporting of causal variants more streamlined and simple. Bionano's flagship product is Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping that helps with understanding of genetic variation and function. The product suite also includes the Saphyr instrument, a high-performance single-molecule imager, and the Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization. In addition, Bionano provides Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company's product offerings also extend to Saphyr and Bionano compute servers, and NxClinical software. This software provides a one-system solution for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. To further expand its offerings, Bionano also provides testing and laboratory services, catering to various genetic disorders. These testing and laboratory services include FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability. Bionano also provides Fragile X syndrome (FXS) testing services, NextStepDx PLUS, an exome sequencing test to identify genetic variants that are associated with disorders of childhood development, and EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures. The company also offers the PGx test, which identifies over 60 alleles in 11 genes. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
Bionano Genomics's ticker is BNGO
The company's shares trade on the NASDAQ stock exchange
They are based in San Diego, California
There are 201-500 employees working at Bionano Genomics
It is bionanogenomics.com
Bionano Genomics is in the Healthcare sector
Bionano Genomics is in the Diagnostic Substances industry
The following five companies are Bionano Genomics's industry peers: